|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2 USD | 0.00% |
|
0.00% | +33.33% |
| Feb. 28 | EARNINGS: Hutchmed revenue surges, Craven House's loss widens | AN |
| Feb. 28 | Craven House Capital Plc Reports Earnings Results for the Half Year Ended November 30, 2023 | CI |
Craven House Capital Plc reported earnings results for the full year ended May 31, 2023. For the full year, the company reported net loss was USD 5.52 million compared to USD 0.236 million a year ago. Basic loss per share from continuing operations was USD 1.4274 compared to USD 0.0611 a year ago.
Diluted loss per share from continuing operations was USD 1.4274 compared to USD 0.0611 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +33.33% | 773K | |
| -5.65% | 113B | |
| +20.42% | 63.85B | |
| +5.42% | 61.9B | |
| +10.97% | 42.86B | |
| +9.70% | 40.84B | |
| +18.55% | 34.58B | |
| +5.56% | 25.46B | |
| -4.75% | 22.13B | |
| +2.01% | 18.61B |
CRAVEN HOUSE CAPITAL PLC 
